The Dodge Ram 1500 has been on the market since 1981, despite its poor safety track record. As anyone who has spent time researching car impact safety ratings knows, some cars provide better protection in the event of a crash than others. Vehicles must meet certain government-mandated safety minimums. These provide only an extremely basic… Read More
Mesh Implants Dangerous and Defective
In what is simply too common a story to our experienced product liability attorneys, mesh implants have become the latest medical treatment to skyrocket in usage, only to be proved dangerous and defective. Mesh implants went rapidly from a new, untested treatment to the standard, go-to treatment for middle aged and older women suffering from… Read More
Investigation Shows Poisonous Chemicals Forced Into U.S. Homes
In the past several years, flame retardants in furniture, mattresses, pillows and other household products have become as common as the items themselves. Indeed, in many cases – and many states – the inclusion of these chemicals is now required by law. An investigation by the Chicago Tribune has revealed, however, that these laws were… Read More
Amgen Pushing Xgeva Despite Documented Danger
Xgeva, whose chemical name is denosumab, is approved for use in those suffering from advanced prostate cancer which has moved into the patient’s bones. The drug is approved to help prevent fractures in these patients. It is administered by injection. The drug is manufactured by Amgen, Inc. Sales of Xgeva have skyrocketed in recent months…. Read More
Heparin Safety Recommendations – Four Years Later
Last month, to the satisfaction of personal injury attorneys nationwide, the U.S. Environmental Protection Agency (the EPA) at last issued its long-awaited final health assessment of the chemichal perchloroethylene, publishing the assessment to the EPA’s Integrated Risk Information System database. The database, known as IRIS, is used by the agency and others to assess human… Read More
Another Dangerous Breast Implant Leads to Criminal Charges in Europe
In yet another blow to the breast implant market, the burgeoning scandal of the implants from Ploy Implant Prothese (known as “PIP”) has rapidly become a medical products liability nightmare. The implants were used in over 400,000 women across 65 countries in Europe and South America. The implants have not been sold in the United… Read More
Heparin Safety Recommendations – Four Years Later
In yet another example of the inadequacy of federal regulators to protect patient health, the FDA this month issued recommendations for measures to ensure that Heparin, the popular blood-clot prevention drug, was produced safely. While our products liability attorneys applaud the issuance of such recommendations, it is important to note that the agency has finally… Read More
Avastin Breast Cancer Approval Withdrawn
This week, the federal Food and Drug Administration announced its withdrawal of approval for Avastin, a commonly-used breast cancer drug. Avastin, the trade name for the drug bevacizumab, is one of a class of drugs known as “biological therapy.” The drug is a product of Genentech, a biotechnology company based in San Francisco, California. Avastin… Read More
Merck Continues Developing Vorapaxar Despite Dangers
Even in the face of disturbing developments concerning its experimental anti-clotting drug Vorapaxar, pharmaceutical giant Merck has shown a disturbing intent to proceed with development of this dangerous product. Vorapaxar was once considered the most important drug in the development pipeline. In fact, as recently as 2009, Wall Street analysts predicted that the drug could… Read More
Dangerous Nurofen Plus Tablets Recalled
Recently, regulators in Great Britain issued a safety alert after finding packets of Nurofen Plus, an over-the-counter painkiller, containing the anti-psychotic prescription drug Seroquel XL instead. After additional packs were found, from other batches, containing both Seroquel XL and Neurontin, an anti-seizure prescription medication, the manufacturer issued a recall of all outstanding unsold packets of… Read More
- « Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 11
- Next Page »